Ceritinib is an oral tyrosine kinase inhibitor and member of the ALK inhibitor class used in the treatment of specific types of non-small cell lung cancer characterized by anaplastic lymphoma kinase gene… Read more



![Chemical structure of 2-[(5-Chloro-4-{[2-(propane-2-sulfonyl)phenyl]amino}pyrimidin-2-yl)amino]-5-methyl-4-(piperidine -4-yl)phenol hydrochloride](/_next/image?url=https%3A%2F%2Fassets.splendidlab.com%2F2-5-Chloro-4-2-propane-2-sulfonylphenylaminopyrimidin-2-ylamino-5-methyl-4-piperidine-4-ylphenol-hydrochloride.png&w=3840&q=75)









Ceritinib is an oral tyrosine kinase inhibitor and member of the ALK inhibitor class used in the treatment of specific types of non-small cell lung cancer characterized by anaplastic lymphoma kinase gene abnormalities. This category provides a comprehensive selection of reference standards designed for pharmaceutical laboratories to facilitate rigorous analytical testing and quality control. By utilizing high-quality Ceritinib API, related pharmacopeial and non-pharmacopeial impurities, and potential metabolites, researchers can ensure accurate impurity profiling and method validation throughout the drug development lifecycle. Additionally, stable isotope-labelled compounds are available to serve as reliable internal standards in complex mass spectrometry applications, supporting the precise quantification and identification of the drug and its degradation products. These materials are essential for laboratories maintaining compliance and consistency in their analytical processes.